| |
|
|
|
|
|
|
|||
|
Blood, 1 October 2008, Vol. 112, No. 7, pp. 2657-2666. Prepublished online as a Blood First Edition Paper on July 7, 2008; DOI 10.1182/blood-2008-03-144634.
CHEMOKINES, CYTOKINES, AND INTERLEUKINS Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes ak Podkraj ek61 Institute of General and Molecular Pathology, University of Tartu, Tartu, Estonia; 2 Institute of Medicine, University of Bergen, Bergen, Norway; 3 Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, United Kingdom; 4 Institute of Medical Technology, University of Tampere, Tampere, Finland; 5 Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; 6 Centre for Medical Genetics and 7 Department of Pediatric Endocrinology, Diabetes and Metabolism, University Children's Hospital, Ljubljana, Slovenia; 8 Department of Medical Sciences, Uppsala University, Uppsala, Sweden; 9 Section of Endocrinology, Akershus University Hospital, University of Oslo, Oslo, Norway; 10 Pediatric Clinic II, Ospedale Microcitemico and Department of Biomedical and Biotechnological Science, University of Cagliari, Sardinia, Italy; 11 Division of Pediatric Endocrionology, UMDNJ/Robert Wood Johnson Medical School, New Brunswick, NJ; 12 Bioseek Clinics, New York, NY; 13 Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland; 14 Dermagene Oy, Tampere, Finland; 15 Division of Molecular Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; 16 Division of Molecular Pathology, Institute of Medical and Veterinary Science and the Hanson Institute, School of Medicine at the University of Adelaide, Adelaide, Australia; and 17 Department of Medicine, Haukeland University Hospital, Bergen, Norway
Neutralizing autoantibodies to type I, but not type II, interferons (IFNs) are found at high titers in almost every patient with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED), a disease caused by AIRE gene mutations that lead to defects in thymic T-cell selection. Combining genome-wide expression array with real time RT-PCR assays, we here demonstrate that antibodies against IFN-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||